Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel Institute for Neuroscience and Human Behavior

Cost: No fee

Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers.

Credit Designations Available: AMA PRA Category 1 Credit™, and Interprofessional Continuing Education (IPCE) credit.

Webinar Description: Once we’ve successfully managed the organizational and clinical steps to initiate treatment for patients with OUD, we need to consider how to best sustain this new service and ensure continued access to high-quality care for our most challenging patients. This session will review long-term staffing structure and needs as buprenorphine (or other pharmacotherapies) become part of the treatment landscape in the community. The session will also review the challenges in delivering buprenorphine treatment to a range of patient populations, including those with comorbid mental health and/or physical health conditions, pregnant patients, those with co-occurring pain, and poor responders.

Educational Objectives:

• Review prescriber clinical considerations including medication changes and tapering
• Discuss prescriber considerations for challenging patient profiles – Co-occurring disorders; pregnancy; pain
• Consider sustainability and on-going planning for long-term medications for addiction treatment program; funding; community engagement; staffing

Continuing Education Information:

In support of improving patient care, this activity has been planned and implemented by Addiction Technology Transfer Center Network and American Academy of Addiction Psychiatry. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional Continuing Education (IPCE) Designation Statement:

This activity was planned by and for the healthcare team, and learners will receive 1 (one) Interprofessional Continuing Education credits for learning and change.

Physician Designation Statement

American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Health Professionals

Participants will receive a Certificate of Attendance stating this program is designated for 1.0 hour AMA PRA Category 1 Credit™. This credit is accepted by the AANP and the AAPA.